Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials
Autor: | Chihara, Dai **, Lin, Ruitao, Flowers, Christopher R, Finnigan, Shanda R, Cordes, Lisa M, Fukuda, Yoko, Huang, Erich P, Rubinstein, Larry V, Nastoupil, Loretta J, Ivy, S Percy, Doroshow, James H, Takebe, Naoko * |
---|---|
Zdroj: | In The Lancet 13-19 August 2022 400(10351):512-521 |
Databáze: | ScienceDirect |
Externí odkaz: |